| UniProt ID | XCT_HUMAN | |
|---|---|---|
| UniProt AC | Q9UPY5 | |
| Protein Name | Cystine/glutamate transporter | |
| Gene Name | SLC7A11 | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 501 | |
| Subcellular Localization |
Membrane Multi-pass membrane protein . |
|
| Protein Description | Sodium-independent, high-affinity exchange of anionic amino acids with high specificity for anionic form of cystine and glutamate.. | |
| Protein Sequence | MVRKPVVSTISKGGYLQGNVNGRLPSLGNKEPPGQEKVQLKRKVTLLRGVSIIIGTIIGAGIFISPKGVLQNTGSVGMSLTIWTVCGVLSLFGALSYAELGTTIKKSGGHYTYILEVFGPLPAFVRVWVELLIIRPAATAVISLAFGRYILEPFFIQCEIPELAIKLITAVGITVVMVLNSMSVSWSARIQIFLTFCKLTAILIIIVPGVMQLIKGQTQNFKDAFSGRDSSITRLPLAFYYGMYAYAGWFYLNFVTEEVENPEKTIPLAICISMAIVTIGYVLTNVAYFTTINAEELLLSNAVAVTFSERLLGNFSLAVPIFVALSCFGSMNGGVFAVSRLFYVASREGHLPEILSMIHVRKHTPLPAVIVLHPLTMIMLFSGDLDSLLNFLSFARWLFIGLAVAGLIYLRYKCPDMHRPFKVPLFIPALFSFTCLFMVALSLYSDPFSTGIGFVITLTGVPAYYLFIIWDKKPRWFRIMSEKITRTLQIILEVVPEEDKL | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 4 | Ubiquitination | ----MVRKPVVSTIS ----CCCCCEEEEEC | 30.65 | 21906983 | |
| 8 | Phosphorylation | MVRKPVVSTISKGGY CCCCCEEEEECCCCC | 21.91 | 25159151 | |
| 9 | Phosphorylation | VRKPVVSTISKGGYL CCCCEEEEECCCCCE | 20.05 | 25159151 | |
| 11 | Phosphorylation | KPVVSTISKGGYLQG CCEEEEECCCCCEEC | 25.90 | 29514088 | |
| 12 | Ubiquitination | PVVSTISKGGYLQGN CEEEEECCCCCEECC | 53.13 | 23000965 | |
| 12 | Ubiquitination | PVVSTISKGGYLQGN CEEEEECCCCCEECC | 53.13 | 21890473 | |
| 12 | Sumoylation | PVVSTISKGGYLQGN CEEEEECCCCCEECC | 53.13 | - | |
| 15 | Phosphorylation | STISKGGYLQGNVNG EEECCCCCEECCCCC | 12.43 | 21945579 | |
| 26 | Phosphorylation | NVNGRLPSLGNKEPP CCCCCCCCCCCCCCC | 54.20 | 22167270 | |
| 30 | Ubiquitination | RLPSLGNKEPPGQEK CCCCCCCCCCCCCHH | 70.56 | 21906983 | |
| 37 | Ubiquitination | KEPPGQEKVQLKRKV CCCCCCHHHHHHHHH | 27.65 | 21906983 | |
| 41 | Ubiquitination | GQEKVQLKRKVTLLR CCHHHHHHHHHHHHH | 32.84 | 22817900 | |
| 43 | Ubiquitination | EKVQLKRKVTLLRGV HHHHHHHHHHHHHCC | 37.67 | 23503661 | |
| 51 | Phosphorylation | VTLLRGVSIIIGTII HHHHHCCHHHHHHHH | 15.76 | - | |
| 222 | Ubiquitination | KGQTQNFKDAFSGRD CCCCCCHHHHHCCCC | 56.55 | 23000965 | |
| 314 | N-linked_Glycosylation | FSERLLGNFSLAVPI CCHHHHCCCCCHHHH | 24.25 | UniProtKB CARBOHYD | |
| 327 | S-palmitoylation | PIFVALSCFGSMNGG HHHHHHHCCCCCCCC | 4.69 | 29575903 | |
| 481 | Phosphorylation | PRWFRIMSEKITRTL CCCHHHHCHHHHHHH | 33.11 | 22673903 | |
| 483 | Ubiquitination | WFRIMSEKITRTLQI CHHHHCHHHHHHHHH | 41.91 | 21906983 | |
| 500 | Ubiquitination | EVVPEEDKL------ HCCCCCCCC------ | 60.42 | 29901268 |
| Modified Location | Modified Residue | Modification | Function | Reference | ||
|---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of XCT_HUMAN !! | ||||||
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of XCT_HUMAN !! | ||||||
| Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
|---|---|---|---|---|
Oops, there are no PPI records of XCT_HUMAN !! | ||||
| Kegg Disease | |
|---|---|
| There are no disease associations of PTM sites. | |
| OMIM Disease | |
| There are no disease associations of PTM sites. | |
| Kegg Drug | |
| There are no disease associations of PTM sites. | |
| DrugBank | |
| DB06151 | Acetylcysteine |
| DB00138 | L-Cystine |
| DB00740 | Riluzole |
| DB01098 | Rosuvastatin |
| DB00795 | Sulfasalazine |
| DB08834 | Tauroursodeoxycholic acid |
loading...
| Phosphorylation | |
| Reference | PubMed |
| "Large-scale proteomics analysis of the human kinome."; Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,Mann M., Daub H.; Mol. Cell. Proteomics 8:1751-1764(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-26, AND MASSSPECTROMETRY. | |
| "Kinase-selective enrichment enables quantitative phosphoproteomics ofthe kinome across the cell cycle."; Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,Greff Z., Keri G., Stemmann O., Mann M.; Mol. Cell 31:438-448(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-26, AND MASSSPECTROMETRY. | |
| "Global, in vivo, and site-specific phosphorylation dynamics insignaling networks."; Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,Mann M.; Cell 127:635-648(2006). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-26, AND MASSSPECTROMETRY. | |